MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Immuno-Oncology, Immunotherapy
Imvaq Therapeutics
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Immuno-Oncology, Immunotherapy
Venture Capital: Series B
Children
2020: Imvaq Therapeutics Raises $15 Million in Series B Financing to Fund IND and Phase 1 Trials
Company is developing novel viral-based, armed immune-stimulating therapies to treat a variety of solid tumors including skin cancers, sarcoma, as well as hard-to-treat tumors such as triple-negative breast cancer.
Viral-based immune system stimulating therapies for solid tumors
Jumps
Memorial Sloan Kettering Cancer Center-(#2 Cancer Center-US New & World Report)